Global sales of robotically assisted surgical systems are expected to increase at a CAGR of 15.7% over the forecast period covered by this newly published Meddevicetracker report, reaching more than $11.4bn in 2025. Although sales were negatively impacted by the COVID-19 pandemic in 2020, competitors have reported significantly improved sales in the fourth quarter of 2020 and the first quarter of 2021.
As robotic assisted surgeries make up fewer than 10% of surgeries performed worldwide, there is much room for growth in this market. More than 150 RAS systems are in use today, and their numbers are proliferating. A number of products are expected to launch during the forecast period covered by this report and/or to receive expanded indications.
This comprehensive medical market and technology report provides:
- a clinical overview of robotic assisted surgery and its current applications
- procedure volumes, by indication, for the leading supplier of robotic surgery systems
- product portfolios offered by leading manufacturers, as well as emerging products
- an in-depth market and competitive analysis
Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.